Please login to the form below

Not currently logged in
Email:
Password:

New CSO for Sanofi

Sanofi has appointed Dr David-Alexandre Gros as the pharmaceutical company's new chief strategy officer, effective September 1, 2011

Sanofi has appointed Dr David-Alexandre Gros as the pharmaceutical company's new chief strategy officer effective, September 1, 2011.

Based in Paris, France, Gros will oversee all Sanofi's business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management.

He will report to Sanofi's' CEO, Christopher A Viehbacher.

Commenting on the appointment, Viehbacher said: "David-Alexandre brings a wealth of experience as a physician, strategic consultant and investment banker. He will be able to contribute significantly to the development and implementation of Sanofi's strategy and transformation."

Gros' previous positions include acting as an advisor to healthcare companies as principal of the healthcare investment banking division at Centerview Partners, as well as holding senior positions at Merrill Lynch and McKinsey & Company.

He was also resident physician at the University of Pennsylvania Health System from 1999 to 2000.

30th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics